Integer Holdings beats Q3 sales, profit estimates
I'm PortAI, I can summarize articles.
Integer Holdings reported Q3 2025 sales of $468 million, an 8% increase, surpassing analyst expectations. Adjusted EPS rose 25% to $1.79. The company forecasts 2025 sales between $1.840 billion and $1.854 billion, with adjusted EPS of $6.29 to $6.43. Growth was driven by a 15% increase in Cardio & Vascular sales, while Neuromodulation saw growth offset by a decline in spinal cord stimulation. The average analyst rating is "buy," with a 12-month price target of $137.50, reflecting a potential 21.5% increase from the recent closing price of $107.94.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments